18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Alice in Wonderland Syndrome as a Presenting Manifestation of Creutzfeldt-Jakob Disease

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Alice in Wonderland syndrome (AIWS) is a rare neurological disorder characterized by distortions of visual perception (metamorphopsias), the body image, and the experience of time, along with derealization and depersonalization. Some 85% of patients present with perceptual distortions in a single sensory modality, e.g., only visual or only somesthetic in nature. Moreover, the majority experience only a single type of distortion, e.g., only micropsia or only macropsia. AIWS has many different etiologies, and hence an extensive differential diagnosis. Its amenability to treatment depends on the underlying pathological process, which in children is mostly encephalitis, and in adults, migraine. In the literature, no more than 180 “clinical” cases of AIWS have been described (i.e., cases in need of medical attention). Of them, some 50% showed a favorable prognosis. However, non-clinical cases (i.e., fleeting, transient cases of AIWS for which no professional help is needed) have been described in up to 30% of the general population. This indicates that AIWS is perhaps not as rare as traditionally assumed, and has led some authors to conclude that, prognostically, AIWS is usually harmless.

          Methods: From our own clinical practice, we describe the first known case of Creutzfeldt-Jakob Disease (CJD, Heidenhain variant) that presented with symptoms of AIWS.

          Results: In our patient, disease onset was sudden and rapidly progressive, starting with isolated visual symptoms. Symptoms of AIWS comprised akinetopsia, chloropsia, micropsia, macropsia, zoom vision, and time distortions (quick-motion phenomenon and protracted duration). Soon, these were complicated by paraesthesias, gait instability, aphasia, expressive amusia, cognitive decline, and behavioral changes in the form of agitation and emotional lability. The diagnosis of probable sporadic CJD was confirmed with the aid of a head MRI and cerebrospinal fluid (14-3-3 protein). In the absence of any treatment options, our patient was discharged home and died within 2 months after his visual symptoms had begun. Autopsy consent was not obtained.

          Conclusion: We conclude that AIWS is not always as harmless as sometimes suggested, and that CJD, although extremely rare, must be part of its extensive differential diagnosis, notably in the presence of rapid cognitive decline.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

          An international study of the epidemiologic characteristics of Creutzfeldt-Jakob disease (CJD) was established in 1993 and included national registries in France, Germany, Italy, the Netherlands, Slovakia, and the United Kingdom. In 1997, the study was extended to Australia, Austria, Canada, Spain, and Switzerland. Data were pooled from all participating countries for the years 1993 to 2002 and included deaths from definite or probable CJD of all etiologic subtypes. Four thousand four hundred forty-one cases were available for analysis and included 3,720 cases of sporadic CJD, 455 genetic cases, 138 iatrogenic cases, and 128 variant cases. The overall annual mortality rate between 1999 and 2002 was 1.67 per million for all cases and 1.39 per million for sporadic CJD. Mortality rates were similar in all countries. There was heterogeneity in the distribution of cases by etiologic subtype with an excess of genetic cases in Italy and Slovakia, of iatrogenic cases in France and the UK, and of variant CJD in the UK. This study has established overall epidemiologic characteristics for Creutzfeldt-Jakob disease (CJD) of all types in a multinational population-based study. Intercountry comparisons did not suggest any relative change in the characteristics of sporadic CJD in the United Kingdom, and the evidence in this study does not suggest the occurrence of a novel form of human bovine spongiform encephalopathy infection other than variant CJD. However, this remains a possibility, and countries currently unaffected by variant CJD may yet have cases.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The syndrome of Alice in Wonderland.

            J. Todd (1955)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.

              The classic Creutzfeldt-Jakob disease (CJD), Heidenhain, and Oppenheimer-Brownell variants are sporadic CJD (sCJD) phenotypes frequently described in the literature, but many cases present with neuropsychiatric symptoms, suggesting that there may be additional sCJD phenotypes. To characterize clinical, diagnostic, and molecular features of 5 sCJD variants. Retrospective analysis. The Johns Hopkins and Veterans Administration health care systems. Eighty-eight patients with definite or probable sCJD. Differences in age at onset, illness progression, diagnostic test results, and molecular subtype. The age at onset differed among sCJD variants (P = .03); the affective variant had the youngest mean age at onset (59.7 years). Survival time (P < .001) and the time to clinical presentation (P = .003) differed among groups. Patients with the classic CJD phenotype had the shortest median survival time from symptom onset (66 days) and those who met criteria for the affective sCJD variant had the longest (421 days) and presented to clinicians significantly later (median time from onset to presentation, 92 days; P = .004). Cerebrospinal fluid analyses were positive for 14-3-3 protein in all of the affective variants, regardless of illness duration. Periodic sharp-wave complexes were not detected on any of the electroencephalography tracings in the Oppenheimer-Brownell group; basal ganglia hyperintensity was not detected on brain magnetic resonance imaging in this group either. All of the Heidenhain variants were of the methionine/methionine type 1 molecular subtype. The classic CJD phenotype and the Heidenhain, Oppenheimer-Brownell, cognitive, and affective sCJD variants differ by age at disease onset, survival time, and diagnostic test results. Characteristics of these 5 phenotypes are provided to facilitate further clinicopathologic investigation that may lead to more reliable and timely diagnoses of sCJD.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Neurol
                Front Neurol
                Front. Neurol.
                Frontiers in Neurology
                Frontiers Media S.A.
                1664-2295
                09 May 2019
                2019
                : 10
                : 473
                Affiliations
                [1] 1Department of Neurology, Onze Lieve Vrouwe Gasthuis , Amsterdam, Netherlands
                [2] 2Department of Neurology, Zaans Medisch Centrum , Zaandam, Netherlands
                [3] 3Outpatient Clinic for Uncommon Psychiatric Syndromes, Parnassia Psychiatric Institute , The Hague, Netherlands
                [4] 4Faculty of Social and Behavioural Sciences, Leiden University , Leiden, Netherlands
                [5] 5Department of Psychiatry, University of Groningen , Groningen, Netherlands
                Author notes

                Edited by: Gianfranco Spalletta, Fondazione Santa Lucia (IRCCS), Italy

                Reviewed by: Maurizio Pocchiari, Istituto Superiore di Sanità (ISS), Italy; Anna Ladogana, Istituto Superiore di Sanità (ISS), Italy

                *Correspondence: Jan Dirk Blom jd.blom@ 123456parnassia.nl

                This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neurology

                Article
                10.3389/fneur.2019.00473
                6521793
                31143156
                04b94f96-7b01-4d28-81ad-720f8a1d5a05
                Copyright © 2019 Naarden, ter Meulen, van der Weele and Blom.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 03 April 2019
                : 18 April 2019
                Page count
                Figures: 2, Tables: 1, Equations: 0, References: 29, Pages: 6, Words: 4351
                Categories
                Neurology
                Case Report

                Neurology
                etiology,heidenhain variant,metamorphopsia,neurodegeneration,prion disease,prognosis,time distortion,visual perception

                Comments

                Comment on this article